Q4 2022 Biogaia AB Earnings Call Transcript
Welcome to BioGaia Q4 Report 2022. (Operator Instructions) Now I will hand the conference over to the speaker CEO, Isabelle Ducellier. Please go ahead.
()-&
Good morning, and welcome to our interim management statement quarter 4 2022. I will as well comment on the whole year '22 prior to the annual report release planned on March 27. So in a nutshell, I will say that we have a strong Q4 with 33% growth in sales and one of the best year of BioGaia at plus 41% sales increase, which allow us for the first time in our 32-year history to pass the SEK 1 billion mark in turnover. And despite the global cost increase, we've been able to maintain our EBIT at 33% even if the Q4 being a bit lower in EBIT margin as it was last year and that's mainly due to the fact that it's a very intense activity in terms of marketing and sales campaign. So the OpEx increase somehow weighs a bit more in Q4 than the rest of the year.
Looking at key events, I just
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |